CURE Stock Direxion Daily Healthcare Bull 3X ETF (CURE) (CURE, $124.04) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 1, 2026
at Tickeron.com
This is a Bearish indicator signaling CURE's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 47 similar cases where CURE's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:
CURE's RSI Indicator leaves overbought zone
The 10-day RSI Oscillator for CURE moved out of overbought territory on August 26, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 29 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 62 of 67 cases where CURE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CURE as a result. In 87 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CURE turned negative on October 01, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 44 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CURE moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for CURE entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The 10-day moving average for CURE crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +2.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where CURE advanced for three days, in 291 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
CURE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.